January 7, 2019 Informatics & Software Life Science Tools Product Launch

Twist Bioscience Enhances Genes Product Offering with Longer Genes and Offers Access to Its Application Programming Interface

January 07, 2019 08:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced it has expanded its product portfolio to offer genes up to five kilobases (5kb) in length at industry-leading pricing. In addition, Twist is making its... Read more

November 26, 2018 PR/Corporate

Twist Bioscience Appoints Experienced Technology Executive Jan Johannessen to Board of Directors

November 26, 2018 05:00 AM Pacific Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the appointment of Jan Johannessen to the company’s board of directors. He will also serve as chair of the audit committee. Mr. Johannessen brings more... Read more

November 26, 2018 Life Science Tools PR/Corporate

Twist Bioscience Appoints Experienced Technology Executive Jan Johannessen to Board of Directors

November 26, 2018 08:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the appointment of Jan Johannessen to the company’s board of directors. He will also serve as chair of the audit committee. Mr. Johannessen brings more... Read more

October 31, 2018 Life Science Tools PR/Corporate

Twist Bioscience Corporation Announces Pricing of Initial Public Offering

October 31, 2018 11:45 AM Pacific Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it has priced its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share, before... Read more

October 30, 2018 Lab Top-10 Licensing, IP, and Legal Life Science Tools

Agilent Sends Letter to the SEC Regarding Material Misstatements in Twist Bioscience’s S-1 Registration Statement

Agilent Sends Letter to the SEC Regarding Material Misstatements in Twist Bioscience’s S-1 Registration Statement SANTA CLARA, Calif., October 29, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it sent a letter to the Division of Corporation Finance of the U.S. Securities and Exchange Commission (SEC) regarding misstatements in the S-1 Registration Statement filed... Read more

October 24, 2018 PR/Corporate

Twist Bioscience Adds Ray Tabibiazar, M.D., as Senior Vice President, Corporate Development and Business Strategy

Download PDF SAN FRANCISCO, Calif.  – October 24, 2018 — Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the appointment of Ray Tabibiazar, M.D., as senior vice president of corporate development and business strategy as well as acting general manager of Twist Bioscience’s division focused on... Read more

September 27, 2018 M&A, Partnerships

The Arch Mission Foundation Announces Digital Data Stored in DNA added to Lunar Library™, Creating Groundbreaking Archive of Knowledge on the Moon

Download PDF Partners for this ambitious effort include Microsoft, Twist Bioscience Corporation, and the University of Washington LOS ANGELES, CA, September 27, 2018 — The Arch Mission Foundation today announced the creation of an archive of knowledge encoded into synthetic DNA by Microsoft, Twist Bioscience Corporation, and the University of Washington to be included in the... Read more

September 18, 2018 Lab Top-10 Licensing, IP, and Legal

Agilent Files New Complaint Against Twist Bioscience Regarding Stolen Agilent Confidential Documents

SANTA CLARA, Calif., September 18, 2018 Agilent Technologies Inc. (NYSE: A) filed a new complaint against Twist Bioscience Corp. (“Twist”) and Emily Leproust. The proposed Second Amended Complaint adds two additional defendants (Twist employee Siyuan Chen and former Twist employee Solange Glaize) and adds new facts that were recently discovered regarding the defendants’ wide-ranging theft... Read more

September 18, 2018 Lab Top-10 Licensing, IP, and Legal Life Science Tools

Twist Bioscience Responds to Agilent’s Latest Specious Claims

Download PDF SAN FRANCISCO, Calif. – September 18, 2018 — Twist Bioscience issued the following statement: Agilent’s wholesale shift in its allegations, two and a half years into its suit, reveals only the weakness of its claims. Agilent’s most recent allegations are gamesmanship, not substance. They omit that more than four months before it sought to change its... Read more

August 22, 2018 Lab Top-10 Licensing, IP, and Legal Life Science Tools

Twist Bioscience Responds to Agilent’s Latest Baseless Complaint

AUG 22, 2018 Download PDF Agilent’s wholesale shift in its allegations, two and a half years into its suit, reveals only the weakness of its claims. Agilent’s most recent allegations are gamesmanship, not substance.  They omit that more than four months before it sought to change its complaint, Twist informed – and provided to Agilent – the... Read more